Suehiro, Youko

Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial.

Falchi, L., Nijland, M., Huang, H., Linton, K. M., Seymour, J. F., Tao, R., Kwiatek, M., Costa, A., Vassilakopoulos, T. P., Greil, R., et al. (2026) · The Lancet

Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research

Cited by 41

In vivo dynamics and adaptation of HTLV-1-infected clones under different clinical conditions

Izaki, M., Yasunaga, J.-I., Nosaka, K., Sugata, K., Utsunomiya, H., Suehiro, Y., Shichijo, T., Yamada, A., Sugawara, Y., Hibi, T., et al. (2021) · PLOS Pathogens

T-cell and Retrovirus StudiesHIV Research and Treatment

Cited by 15